394 related articles for article (PubMed ID: 10379885)
1. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
[TBL] [Abstract][Full Text] [Related]
2. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
3. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
4. SMAD3 regulates gonadal tumorigenesis.
Li Q; Graff JM; O'Connor AE; Loveland KL; Matzuk MM
Mol Endocrinol; 2007 Oct; 21(10):2472-86. PubMed ID: 17595316
[TBL] [Abstract][Full Text] [Related]
5. Role of androgens in testicular tumor development in inhibin-deficient mice.
Shou W; Woodruff TK; Matzuk MM
Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
7. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
Burns KH; Agno JE; Sicinski P; Matzuk MM
Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
[TBL] [Abstract][Full Text] [Related]
9. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
[TBL] [Abstract][Full Text] [Related]
10. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.
Kumar TR; Wang Y; Matzuk MM
Endocrinology; 1996 Oct; 137(10):4210-6. PubMed ID: 8828479
[TBL] [Abstract][Full Text] [Related]
12. Genetic engineering to study testicular tumorigenesis.
Yan W; Burns KH; Matzuk MM
APMIS; 2003 Jan; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
14. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.
Wu X; Chen L; Brown CA; Yan C; Matzuk MM
Mol Endocrinol; 2004 Jun; 18(6):1509-19. PubMed ID: 15016837
[TBL] [Abstract][Full Text] [Related]
15. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
[TBL] [Abstract][Full Text] [Related]
16. Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.
Rilianawati ; Kero J; Paukku T; Huhtaniemi I
J Endocrinol; 2000 Jul; 166(1):77-85. PubMed ID: 10856885
[TBL] [Abstract][Full Text] [Related]
17. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary.
Hirst RC; Abel MH; Wilkins V; Simpson C; Knight PG; Zhang FP; Huhtaniemi I; Kumar TR; Charlton HM
Reproduction; 2004 Jul; 128(1):43-52. PubMed ID: 15232063
[TBL] [Abstract][Full Text] [Related]
18. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions.
Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ
Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665
[TBL] [Abstract][Full Text] [Related]
19. Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.
Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM
Mol Endocrinol; 2003 Oct; 17(10):2039-52. PubMed ID: 12855748
[TBL] [Abstract][Full Text] [Related]
20. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
